Found 0 matching trials
Pilot Study of SBRT and CDX-1127 in Prostate Cancer PHASE1 This study evaluates the combination of stereotactic body radiation therapy...
Show More Location
University of Virginia
Learn More & Join Trial
Phaes Ⅱ Study of Golidocitinib-Pegaspargase-PD-1 Antibody First-Line for Advanced ENKTL PHASE2 Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive non-Hodg...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas PHASE2 This research study is studying a combination of drugs (chemotherapy + Immu...
Show More Location
Massachusetts General Hospital Cancer Center
Learn More & Join Trial
Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL) PHASE2 Objectives:
Primary objective: Evaluate toxicity of rapamycin when used fo...
Show More Location
Primary Children's Medical Center
Learn More & Join Trial
Assessing the Ability of the T-SPOT®.TB Test (IQ) N/A The primary objective of this clinical research study is to demonstrate per...
Show More Location
University of Texas Health
Learn More & Join Trial
Study of TQB2450 Combined With Anlotinib in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) PHASE1 TQB2450 is a humanized monoclonal antibody targeting programmed death ligan...
Show More Location
Gansu Province Tumor Hospital
Learn More & Join Trial
Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer PHASE1 This phase I trial studies the side effects and best dose of autologous CD8...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
T Cell Response in Hypersensitivity Syndrome N/A immunological study of the T cell repertoire phenotype and functionality in...
Show More Learn More & Join Trial
Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma PHASE2 This phase II trial studies how well nivolumab works in treating patients w...
Show More Learn More & Join Trial
Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer PHASE2 This phase II trial studies how well ipilimumab works when given together w...
Show More Location
Rutgers Cancer Institute of New Jersey
Learn More & Join Trial